Market forces ‘insufficient’ to roll out low-cost tech

Using market dynamics to roll out new technologies for development can bring unexpected challenges, say the developers of a low-cost innovation to treat jaundice in newborn babies, whose initial plan to let the tech ‘sell itself’ backfired.